A study on efficacy of tranexemic acid in reducing cesarean section blood loss.
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: AIMS OF THE STUDY:
1. To find whether tranexamic acid is effective in reducing
peroperative and postoperative blood loss in lower segment
caesaerean section.
2. To find whether tranexamic acid is associated with any adverse reactions or complications.
MATERIALS AND METHODS:
The study was done by Dr.D. Punitha Meenakshi at Government Chengalpattu Medical College Hospital between November 2013 to August 2014.The source of data for this study are patients who were admitted in the Antenatal ward and Labour ward who were planned for elective and emergency caesarean section at Chengalpattu Medical College Hospital, Chengalpattu.
Inclusion Criteria:
1. Primi and second gravida with term gestation,
2. Singleton pregnancy,
3. Emergency and elective cases for caesarean section.
Exclusion Criteria:
1. Allergic to tranexamic acid
2. Severe medical illness like cardiac, Renal and Liver diseases
3. Patients with past history of thromboembolic disorders.
4. Complicated pregnancies at risk of PPH.
• PIH, Preeclampsia,
• HELLP,
• Anaemia with Hb < 9gms%,
• Abnormal placenta –Abruptio placenta,Placenta previa,
• Polyhydromnios,
• Multiple pregnancy,
• Estimated fetal weight > 4kgs (Macrosomia),
• Myoma uterus with pregnancy,
• Prolonged labour,
• Anesthesia-Halogenated /General anesthesia.
METHODS:
The subjects of this Randomized Controlled trial were 200
patients who were admitted for elective and emergency
caesarean section in labour ward and antenatal ward.
• Detailed obstetric and Medical History was taken in all patients.
Their weight and Height were recorded. Vital parameters were
checked. General, systemic and obstetric examination was done.
USG was done to confirm gestational age, fetal wellbeing,
liquor status. Complete blood count at the time of admission
and on 3 rd postoperative period was done. Bleeding Time,
Clotting Time at the time of admission. Renal and Liver
function test at the time of admission and on 3 rd postoperative period. Urine was examined for Albumin, Sugar and Deposits
during admission
• Subjects were randomized by BLOCK RANDOMIZATION.
• 100 Antenatal women were placed in STUDY GROUP
(Group A ) and 100 antenatal women were placed in
CONTROL GROUP(GROUP B) with the same inclusion and
exclusion criteria.
• All patients were informed about the study and the effects of drug Tranexamic acid and consent was obtained after
counseling the patients.
STUDY GROUP:
• Patient in this group received injection Tranexamic acid
15mg /kg dose infusion in 100 ml Ringer lactate solution
over 10 - 15 minutes prior to the skin incision.
• After Delivery of Baby during Cesarean Section, they received Injection oxytocin 10 units indramuscularly.
CONTROL GROUP:
• Patient in this group did not receive injection Tranexamic acid. Just they received plain Ringer lactate. Lower segment
caesarean section was done under spinal anesthesia.
• After the delivery of the baby, they received Injection oxytocin 10 units intramuscularly.
• Both groups received parentral Antibiotics just prior to surgery.
CONCLUSION:
There is no significant difference in Age, BMI, Parity, Indication and Duration of Cesarean Section and Birth weight of Baby between the study group and control group. Both Groups are comparable.
Intravenous infusion of Tranexemic Acid at the dose of 15 mg/Kg Body Weight, initiated 15 minutes prior to Skin Incision.
• does not alter the (1) Heart rate, (2) Systolic BP, (3)
Diastolic BP and (4) Respiratory Rate.
• leads to significant reduction (p <0.05) in Per Operative
(average 114.40 ml) and Post Operative Blood Loss (average
32.77 ml) during Cesarean Section. Total Blood Loss is
reduced by an average of 147 ml.
• leads to significant (p <0.05) difference in fall of Hb level in control group who have not received inj.Tranexamic acid.
The mean difference was 0.28gms%(P=0.01)
• leads to Reduction in (1) the incidence of PPH, (2) need for maternal blood Transfusion, (3) Use of additional
Uterotonics, (4) Duration of stay in an insignificant manner
• does not alter the APGAR Score and Rate of admission into
NICU, in a significant manner.
• does not produce other adverse reactions like nausea,
vomiting, diarrhea in a significant manner. It was not
associated with thrombotic complications.
Intravenous infusion of Tranexemic Acid at the dose of 15 mg/Kg Body Weight, initiated 15 minutes prior to Skin Incision is effective and safe in women undergoing caesarean section in reducing preoperative and postoperative cesarean section blood loss
Authors: M. Thangamani, D. Punitha Meenakshi
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: tranexamic acid, cesarean section, postpartum hemorrhage, blood loss, lower segment caesarean section, emergency cesarean section, elective cesarean section, adverse drug reactions, renal function, liver function, hemostasis, obstetric hemorrhage management, maternal morbidity, hemostatic agents
Open Access status: diamond
OpenAlex ID: W2913579676
